Reply to 'Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease' by U. Gueth et al

Affiliations

¹ Division of Medical Oncology, Kantonsspital, Lucerne, Switzerland. Electronic address: stefan.aebi@onkologie.ch.
² Department of Oncology, Royal Free Hampstead NHS Trust and Royal Free and University College Medical School, London, UK.
³ Department of Radiotherapy, Klinik Hirslanden and Swiss Group for Clinical Cancer Research, Zürich, Switzerland.
⁴ Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal.

Free article

Comment

S Aebi et al. Ann Oncol. 2013 Feb.

Free article

. 2013 Feb;24(2):557.

doi: 10.1093/annonc/mds639.

¹ Division of Medical Oncology, Kantonsspital, Lucerne, Switzerland. Electronic address: stefan.aebi@onkologie.ch.
² Department of Oncology, Royal Free Hampstead NHS Trust and Royal Free and University College Medical School, London, UK.
³ Department of Radiotherapy, Klinik Hirslanden and Swiss Group for Clinical Cancer Research, Zürich, Switzerland.
⁴ Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal.

No abstract available

Comment on

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Aebi S, Davidson T, Gruber G, Cardoso F; ESMO Guidelines Working Group. Aebi S, et al. Ann Oncol. 2011 Sep;22 Suppl 6:vi12-24. doi: 10.1093/annonc/mdr371. Ann Oncol. 2011. PMID: 21908498 No abstract available.
Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease.
Güth U, Vetter M, Huang DJ, Heinzelmann-Schwarz V. Güth U, et al. Ann Oncol. 2013 Feb;24(2):555-557. doi: 10.1093/annonc/mds637. Ann Oncol. 2013. PMID: 23341481 No abstract available.